Atlas Trials

The Impact of the Oncotype DX® Breast Cancer Assay on Treatment Decisions in a Canadian Population

Clinical trial NCT02347449 · COMPLETED

Trial details

NCT number
NCT02347449
Sponsor
Sunnybrook Health Sciences Centre
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Hormone Receptor Positive Malignant Neoplasm of Breast
Start date
2014-10-01
Primary completion
2016-09-30
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.